A recent report showed that MALAT-1 is an Sp1-regulated gene [13] and we therefore determined if ROS-inducing anticancer agents that downregulate Sp1, Sp3 and Sp4 in pancreatic and other cancer cell lines also decrease MALAT-1 expression. This evidence concerns the gene SP1 and cancer.